Nebulized Nitroglycerin for Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome: A Case Report
Recommended Citation
Daxon BT, Lark E, Matzek LJ, Fields AR, and Haselton KJ. Nebulized Nitroglycerin for Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome: A Case Report. A A Pract 2021; 15(2):e01376.
Document Type
Article
Publication Date
2-5-2021
Publication Title
A A Pract
Abstract
We present a case where nitroglycerin tablets dissolved in saline and intravenous nitroglycerin solution were nebulized as surrogates for inhaled nitric oxide (iNO) after our iNO supply was depleted during the coronavirus disease 2019 (COVID-19) surge in New York. We gave this treatment to a COVID-19 patient with severe acute respiratory distress syndrome (ARDS) and hypercarbia. In response, the patient had immediate and clinically meaningful improvement in multiple organ systems despite no other interventions or ventilator changes.
Medical Subject Headings
COVID-19; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nitroglycerin; Respiratory Distress Syndrome; Vasodilator Agents
PubMed ID
33560642
Volume
15
Issue
2
First Page
01376
Last Page
01376
